We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

AI-Powered Software Aims to Achieve 6x Reduction in Radiation Dose of Fluoroscopy Exams

By MedImaging International staff writers
Posted on 09 Feb 2022
Print article
Image: SubtleIR AI software (Photo courtesy of Subtle Medical, Inc.)
Image: SubtleIR AI software (Photo courtesy of Subtle Medical, Inc.)

An innovative artificial intelligence (AI)-powered software uses deep learning (DL) to reduce radiation dosage needed during fluoroscopy exams.

Subtle Medical, Inc. (Menlo Park, CA, USA) has been awarded an NIH SBIR grant to develop the AI-powered software, SubtleIR, in line with the company's mission to accelerate access to faster, safer, and smarter medical imaging. This is the second NIH SBIR grant awarded to Subtle. The first was for SubtleGAD, an AI-based software using deep learning to drastically reduce contrast dosage needed during contrast-enhanced medical imaging exams.

Fluoroscopy is a common tool for image-guided interventions in surgeries. The new software will potentially reduce radiation exposure in the operating room, minimizing the risk of cancer development for both patients and radiology staff. Subtle aims to enhance fluoroscopy videos acquired with up to 83% lower dose levels into videos with full-dose quality. This conversion will be performed in real-time, such that the surgeon can receive video feedback without delay while greatly reducing radiation exposure to both the patient and operating clinicians.

In addition, Subtle aims to optimize the processing speed of these DL models by leveraging various software and hardware accelerations for real-time application to achieve over a 30 fps processing rate, which will enable a seamless integration between video capture and subsequent display. Recent research on SubtleIR's technology was published at MICCAI showing a 4x dose reduction while providing equivalent or better video quality to the normal dosage level, as supported by quantitative metrics and surgeon review.

"Receiving this SBIR grant will allow us to meet the demand for new AI applications that support image guided therapy and surgeries. With this technology, hospitals and imaging centers will be able to deliver safer low-dose fluoroscopy exams without sacrificing the clinical quality of the images," said Enhao Gong, PhD, Co-founder & CEO. "We appreciate the NIH's support in the development of this novel AI product and look forward to deploying it in clinical settings."

Related Links:
Subtle Medical, Inc. 

Wall Fixtures
MRI SERIES
New
Specimen Radiography System
Trident HD
HF Stationary X-Ray Machine
TR20G
Ultrasound Imaging System
P12 Elite

Print article

Channels

MRI

view channel
Image: The AI tool can help interpret and assess how well treatments are working for MS patients (Photo courtesy of Shutterstock)

AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans

Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more